According to this study: Mindfulness-based stress reduction is well tolerated and has comparable effectiveness to a first-line medication for people who have anxiety disorders.At least one study-related adverse event occurred in 78.6% of patients in the escitalopram group and in 15.4% of those in the mindfulness-based stress reduction group.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.